drugset
drugset / Trial / NCT00590317

Ondansetron vs Prochlorperazine for Nausea and Vomiting in the Emergency Department

NCT00590317 ↗

Phase 2 Completed 64 enrolled Emory University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will compare the effect of prochlorperazine and ondansetron for the treatment of nausea and vomiting in the emergency department.

Timeline

Start
2005-03
Primary completion
2008-09
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ondansetron Other / unclassified 4 mg Intravenous
Comparator Prochlorperazine Small molecule 10 mg Intravenous

Indications

No indication recorded.